MMP9 and early-onset autosomal dominant Alzheimer disease: Patients with Alzheimer’s disease, multiple sclerosis, amyotrophic lateral sclerosis, stroke, spinal cord injury, or epilepsy are known to have increased MMP-9 and MMP-2 levels in the central nervous system [47,48,49,50,51].